Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 885 of 5804
-
Home visits may boost heart health for pregnant women in nigeria
Disease control OngoingThe purpose of the ENHANCE-CVH study is to promote intergenerational cardiovascular health (CVH) of women and children in Abuja and the surrounding Federal Capital Territory of Nigeria. The study team plans to achieve this through an adaptation of an existing evidence based inter…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New obesity drug VK2735 enters final testing phase
Disease control OngoingThis is a phase 3, multicenter, 78-week randomized, double-blind, placebo-controlled, parallel arm study that will evaluate the weight loss efficacy as well as safety, tolerability, pharmacodynamic effects, and pharmacokinetics of VK2735 in adults who are obese (BMI ≥30 kg/m2) or…
Phase: PHASE3 • Sponsor: Viking Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New triple therapy aims to tame type 2 diabetes
Disease control OngoingThis study is a multicenter, randomized, double-blind, parallel-controlled, phase III clinical trial to evaluate efficacy and safety of the triple combination therapy of prusogliptin, dapagliflozin and metformin in subjects with type 2 diabetes who have inadequate glycemic contro…
Phase: PHASE3 • Sponsor: CSPC Ouyi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
More zaps, better rhythm? trial tests extra ablations for AFib
Disease control Recruiting nowPulmonary vein isolation (PVI) by catheter ablation (CA) has become a widely accepted interventional treatment for patients with symptomatic atrial fibrillation (AF) despite anti-arrhythmic drugs (AAD). Classic thermal ablation modalities use radiofrequency energy or cryo-energy …
Phase: NA • Sponsor: R&D Cardiologie • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New heart valve procedure could offer a gentler option for leaky valve patients
Disease control Recruiting nowTo demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR)
Phase: NA • Sponsor: JenaValve Technology, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Could blood thinners stop a second stroke? new trial investigates
Disease control Recruiting nowPatients who have recently had an ischemic stroke with no clear cause might have undetected atrial fibrillation (AF) that isn't caught during their initial hospital stay. After discharge, these patients are typically monitored for AF using devices like Holter monitors or implanta…
Phase: PHASE4 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Experimental drug combo aims to tackle tough colorectal cancer
Disease control OngoingThis is an open label, randomized, two arm, multi-center study to explore the effect of leronlimab on the overall response rate/ overall survival and safety and tolerability when used in combination with trifluridine and tipiracil + bevacizumab in patients with MSS, mCRC who have…
Phase: PHASE2 • Sponsor: CytoDyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
AI stethoscope aims to spot silent heart and lung disease
Diagnosis Recruiting nowThis is a prospective, observational study evaluating whether heart sounds (phonocardiograms) and three-lead electrocardiograms (ECGs) recorded using the Eko CORE 500 digital stethoscope can help detect pulmonary hypertension (PH) and low left ventricular ejection fraction (EF ≤ …
Sponsor: Eko Devices, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 14:00 UTC
-
New stroke device shows promise in clearing brain blockages
Disease control OngoingTo compare safety and effectiveness of NeVa Stent Retriever (SR) to Control SR in the treatment of stroke caused by large vessel occlusion. The main questions it aims to answer are: How do recanalization rates for NeVa SR compare with those of the Control SR? How does NeVa SR sa…
Sponsor: Vesalio • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Red wine compound may supercharge strength training for seniors
Disease control Recruiting nowThe main goal of this study is to find out if supplementing with resveratrol improves skeletal muscle adaptations to strengthening exercise (resistance training or strength training) in adults age 60+, and to determine whether circulating vehicles of inter-organ communication (ex…
Phase: NA • Sponsor: Texas Tech University • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New mRNA bird flu vaccine enters human testing
⭐️ VACCINE ⭐️ CompletedThis is a phase 1, multicenter, randomized, double-blind trial of two influenza A/H5 mRNA-based vaccines on healthy adult participants, 18-49 years of age. Stage 1 will serve as the open-label, dose finding stage. The first 10 participants will receive 12.5 mcg of H5 AC-Anhui RNA…
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:07 UTC
-
Could low oxygen boost walking recovery in spinal cord injury?
Symptom relief Recruiting nowThe purpose of this study is to determine how combining bouts of low oxygen, transcutaneous spinal cord stimulation, and walking training may improve walking function for people with chronic spinal cord injury of different age groups.
Phase: NA • Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New blood test could spot ovarian cancer type before surgery
Diagnosis Recruiting nowThe study aims to improve the diagnosis of ovarian cancer by distinguishing between borderline ovarian tumors (BOT) and stage I invasive ovarian cancer. Other than the traditional diagnostic biomarker CA125, the previous study TRANS-IOTA (translational-international ovarian tumor…
Sponsor: KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Jail study tests monthly shot to keep opioid treatment on track after release
Disease control Recruiting nowThis application describes a 3-year, randomized controlled trial. Eligible, consenting adults (N=200) with existing sublingual buprenorphine (SLB) prescriptions who enter Middlesex County House of Corrections (MCHOC) as pre-trial detainees will be randomized at admission on a 1:1…
Phase: PHASE4 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 26, 2026 16:42 UTC
-
AI eye doctor: could a computer spot Blindness-Causing diseases faster than humans?
Diagnosis Recruiting nowThis study aims to evaluate the effectiveness of an artificial intelligence (AI)-assisted screening system in ophthalmic diagnosis. Using AI-based fundus photography, the system will assist physicians in diagnosing three common eye diseases: age-related macular degeneration and d…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Diagnosis
Last updated Jul 24, 2026 00:00 UTC
-
Athletic shoe tech could revolutionize prosthetic arm sockets
Disease control Recruiting nowThis research and development will improve upon and investigate the potential validity of an innovative new transradial socket and harness design (the KSH system) that offers an alternative to standard hard sockets and rubber liners with a hybrid polymer and textile-based design …
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Eye implant could replace daily drops for glaucoma
Disease control OngoingThe goal of this clinical trial is to determine the dose of PA5108 Ocular Implant that is effective and safe for the reduction of intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension, compared to the standard treatment therapy.
Phase: PHASE2 • Sponsor: PolyActiva Pty Ltd • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
One surgery, two problems: new device takes on glaucoma and cataracts together
Disease control OngoingA study to assess the safety of the Helix Surgical System in cataract surgery and to gain early evidence of its effectiveness in lowering intraocular pressure (IOP) in subjects with mild to moderate primary open-angle glaucoma (POAG) and cataracts.
Phase: NA • Sponsor: Sight Sciences, Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New titanium implant could let amputees ditch the socket
Disease control Recruiting nowPurpose: Aim 1: Quantify soft tissue complications and infections of service members with transtibial amputations treated with OPRA OI and compare them to transfemoral OI service members. Aim 2: Compare the validated domains, such as functional, quality of life and pain scores,…
Phase: NA • Sponsor: Walter Reed National Military Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New obesity drugs enter human trials in china
Disease control OngoingThis study is to assess the safety and tolerability, PK characterisation, efficacy, and immunogenicity of the study intervention, and it allows assessment of the monotherapy or combination therapy of AZD6234 and AZD9550 in different sub-studies.
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC